500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months
to gather general health information.
Ages:18 and older
Inclusion Criteria: - Psoriasis patients who are prescribed alefacept consistent with product labeling are eligible for enrollment.
Sponsor: Astellas Pharma Inc
Phase: Phase 4
Trial ID: NCT00454701
Not Accepting Healthy Volunteers